This News From Novo: A Warning for Eli Lilly Shareholders
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Benchmarks help you measure performance. This intro explains which indices serve as benchmarks and how investors use them to compare risk and return.
20,611 articlesA GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
After a challenging stretch, small-cap stocks may be poised for a revival in 2026. This guide breaks down the signals...
At a Miami conference this week, Tom Lee floated a $22,000 Ethereum target, tying it to a mix of Bitcoin price milest...
Canoo has begun production of its electric vans, but internal documents show missing parts and late payments that cou...
Plaid’s CFO highlights a surge in internal AI experiments as teams share weekend builds. The push comes as Plaid expa...
Netflix reports revenue growth driven by ads and a leaner strategy, while Disney posts margins and park revenue gains...
Viant DSP is navigating a fast-changing ad-tech landscape in 2026. This analysis breaks down Q1 dynamics, what the nu...
A Dallas-area restaurant owner says geopolitical tensions are pushing up costs and disrupting deliveries, squeezing m...
Could tenant protections actually coexist with strong returns? This guide digs into the math, the risks, and the stra...
Nexxn (NEXN) 2026 earnings signal how the company is navigating growth, profitability, and capital allocation. This g...
IMDX kicked off 2026 with a solid Q1 showing, delivering revenue growth and improving margins while guiding higher fu...
Investors are watching the CLARITY Act as the Senate considers the bill this week. Traders say crypto markets massive...